Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Senechal

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|January 25, 2025
Risk Assessment Prior to Cardiotoxic Anticancer Therapies in 7 StepsJieli Tong, Isabelle Senechal, Sivatharshini Ramalingam, et al.
Cardio-Oncology (London, England)|April 11, 2024
Cancer therapy related cardiac dysfunction as a result of PanitumumabIsabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|August 22, 2024
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditisJieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|March 8, 2024
Late cardiotoxicity related to HER2-targeted cancer therapyIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Current Oncology Reports|September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated CardiotoxicityIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Journal of Hospital Medicine (London, England : 2005)|January 25, 2025
Risk Assessment Prior to Cardiotoxic Anticancer Therapies in 7 StepsJieli Tong, Isabelle Senechal, Sivatharshini Ramalingam, et al.
Cardio-Oncology (London, England)|April 11, 2024
Cancer therapy related cardiac dysfunction as a result of PanitumumabIsabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|August 22, 2024
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditisJieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|March 8, 2024
Late cardiotoxicity related to HER2-targeted cancer therapyIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Current Oncology Reports|September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated CardiotoxicityIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Pageof 1